Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D04AA32	DERMAMINE ITCH STOPPING	G	Diphenhydramine HCl - 1%, Zinc acetete - 0.1%		Cream	560,382 L.L
D04AX01	DOXIDERM	G	Doxepin (HCl) - 5%	5%	Cream	1,037,958 L.L
D06AX01	DERMICIN	G	Fusidic acid - 20mg/g	20mg/g	Cream	175,339 L.L
D06AX01	DERMOFUCIN	G	Fusidic acid - 2%	2%	Cream	290,270 L.L
M01AB05	DICLORETARD	G	Diclofenac sodium - 100mg	100mg	Capsule, sustained release	445,388 L.L
A11CC05	D-ESTER	G	Vitamin D3 - 10000IU	10000IU	Capsule, soft gelatin	999,563 L.L
A11CC03	DERIL	G	Alfacalcidol - 1mcg	1mcg	Capsule, soft	783,460 L.L
G04CB02	DUTASTERIDE BIOGARAN	G	Dutasteride - 0.5mg	0.5mg	Capsule, soft	1,112,702 L.L
N06AX16	DEPREVIX HELLAS	G	Venlafaxine - 75mg	75mg	Capsule, prolonged release	564,414 L.L
N06AX16	DEPREVIX HELLAS	G	Venlafaxine - 75mg	75mg	Capsule, prolonged release	564,414 L.L
N06AX16	DEPREVIX HELLAS	G	Venlafaxine - 150mg	150mg	Capsule, prolonged release	968,910 L.L
N06AX16	DEPREVIX HELLAS	G	Venlafaxine - 150mg	150mg	Capsule, prolonged release	968,910 L.L
A11CC05	D-VITAL	G	Vitamin D3 - 50,000IU	50,000IU	Capsule, hard	712,620 L.L
L01EL01	DULLARMA	G	Ibrutinib - 140mg	140mg	Capsule, hard	422,860,803 L.L
L01EL01	DULLARMA	G	Ibrutinib - 140mg	140mg	Capsule, hard	L.L
G04CA52	DUTAMSUVITAE	G	Tamsulosin HCl - 0.4mg, Dutasteride - 0.5mg		Capsule, hard	2,168,962 L.L
B01AE07	DAXATRAN	G	Dabigatran etexilate (mesilate) - 75mg	75mg	Capsule, hard	2,576,338 L.L
B01AE07	DAXATRAN	G	Dabigatran etexilate (mesilate) - 110mg	110mg	Capsule, hard	2,576,338 L.L
B01AE07	DAXATRAN	G	Dabigatran etexilate (mesilate) - 150mg	150mg	Capsule, hard	2,576,338 L.L
N06AX21	DULOXETINE BIOGARAN	G	Duloxetine HCl - 60mg	60mg	Capsule, gastro-resistant	573,821 L.L
N06AX21	DULOXETINE BIOGARAN	G	Duloxetine HCl - 30mg	30mg	Capsule, gastro-resistant	573,821 L.L
N06AX16	DEFAXINE	G	Venlafaxine (HCl) - 75mg	75mg	Capsule, extended release	724,395 L.L
M01AB05	DIVIDO 75MG	B	Diclofenac sodium - 75mg	75mg	Capsule, dual release	502,597 L.L
A02BC06	DEXILANT	B	Dexlansoprazole - 30mg	30mg	Capsule, delayed release	1,595,141 L.L
A02BC06	DEXILANT	B	Dexlansoprazole - 60mg	60mg	Capsule, delayed release	2,375,914 L.L
N06AX21	DULOXA 60	G	Duloxetine HCl - 60mg	60mg	Capsule, delayed release	831,903 L.L
N06AX21	DULOXA 30	G	Duloxetine HCl - 30mg	30mg	Capsule, delayed release	716,716 L.L
A02BC01	DIGCAP	G	Omeprazole - 20mg	20mg	Capsule	593,850 L.L
J01FF01	DALACIN-C	B	Clindamycin HCl - 150mg	150mg	Capsule	287,582 L.L
J01FF01	DALACIN-C	B	Clindamycin HCl - 300mg	300mg	Capsule	478,408 L.L

...